Overexpression of Lnk using retroviruses has been shown to attenuate growth of hematopoietic leukemic cell-lines but not cells derived from solid tumors, indicating Lnk as a potent candidate in cancer therapy of hematopoietic-origin malignancies [28]. Here, SH2B3 is linked to cancer.